Neil William Aubuchon - 12 Jan 2026 Form 3 Insider Report for Viking Therapeutics, Inc. (VKTX)

Signature
/s/ Michael Morneau, as Attorney-in-Fact
Issuer symbol
VKTX
Transactions as of
12 Jan 2026
Net transactions value
$0
Form type
3
Filing time
26 Jan 2026, 19:55:53 UTC
Next filing
10 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Aubuchon Neil William Chief Commercial Officer 9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO /s/ Michael Morneau, as Attorney-in-Fact 26 Jan 2026 0002106781

No securities are beneficially owned.